G Agnes - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock G Agnes’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
img
Locations:
Stages:

Social media:

Past investments:

  • Geltor
  • Multus
  • UPSIDE Foods
  • Oakbio
  • Advanced Microbubbles
  • Chronus Health
  • Lypid
  • Pando Nutrition Inc.
  • Electro-Active Technologies
  • Stämm Biotech
  • NeuroQore
  • Vivid Vision
  • Serenity Bioworks
  • Osiris Bio
  • DNALite Therapeutics
  • renegade.bio
  • Intrinsic Medicine
  • Quartolio
  • Convalesce
  • Decomer Technology
  • Srnalytics
  • NotCo
  • Ravata Solutions
  • Scindo
  • Dalton Bioanalytics
  • Michroma
  • Calyx
  • Liberum
  • 11 Biomics
  • Clinicai
  • Prellis Biologics
  • FabricNano
  • Diadem Biotherapeutics
  • Primitives
  • Catalog
  • Biomage
  • BiomeSense
  • Dahlia Biosciences
  • Blue Planet Ecosystems
  • QuantumCyte
  • Joywell Foods
  • NovoNutrients
  • Ten63 Therapeutics
  • Membio
  • BioROSA Technologies
  • Endless West
  • Beeline Therapeutics
  • Ivy Natal
  • Carbix
  • Sugarlogix
  • Avisa Myko
  • BioLumen
  • Alora
  • MycoWorks
  • Chi Botanic
  • Circularis Biotechnologies
  • Ecoli Sense
  • Guided Clarity
  • Crimson Dynamics
  • Huue
  • Arcturus BioCloud
  • Khepra
  • Spintex
  • Reazent
  • EMBER Medical
  • Mendel.ai
  • BioAesthetics
  • Osiris Therapeutics
  • Diptera
  • CorNatural
  • Antibiotic Adjuvant
  • ANA Therapeutics

Investor Profile

G Agnes is a Investment Partner, Angel/Individual, Investor, Venture Capital, Design Operator based in Bangkok, Bangkok, Thailand with a diverse investment portfolio that includes companies such as Geltor, Multus, UPSIDE Foods, Oakbio, Advanced Microbubbles, Chronus Health, Lypid, Pando Nutrition Inc., Electro-Active Technologies, Stämm Biotech, NeuroQore, Vivid Vision, Serenity Bioworks, Osiris Bio, DNALite Therapeutics, renegade.bio, Intrinsic Medicine, Quartolio, Convalesce, Decomer Technology, Srnalytics, NotCo, Ravata Solutions, Scindo, Dalton Bioanalytics, Michroma, Calyx, Liberum, 11 Biomics, Clinicai, Prellis Biologics, FabricNano, Diadem Biotherapeutics, Primitives, Catalog, Biomage, BiomeSense, Dahlia Biosciences, Blue Planet Ecosystems, QuantumCyte, Joywell Foods, NovoNutrients, Ten63 Therapeutics, Membio, BioROSA Technologies, Endless West, Beeline Therapeutics, Ivy Natal, Carbix, Sugarlogix, Avisa Myko, BioLumen, Alora, MycoWorks, Chi Botanic, Circularis Biotechnologies, Ecoli Sense, Guided Clarity, Crimson Dynamics, Huue, Arcturus BioCloud, Khepra, Spintex, Reazent, EMBER Medical, Mendel.ai, BioAesthetics, Osiris Therapeutics, Diptera, CorNatural, Antibiotic Adjuvant, ANA Therapeutics. Over time, G Agnes has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether G Agnes is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Enterprise, Web Design, Chemical, Web3/Blockchain, Product Design, Information Technology (IT), Biotech, EnergyTech, Software, Biotechnology, ClimateTech / CleanTech, RetailTech, Consumer Internet, User Experience Design, Impact Investing, Web Development, Internet, Nanotechnology, Web3/Crypto may find it worthwhile to explore potential connections with G Agnes, as their portfolio suggests a familiarity and interest in this area.

Understanding G Agnes’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today